Global Ocular Gene Therapy Market Research Report 2026

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ocular Gene Therapy Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Gene Replacement Technology
1.2.3 Gene Editing Technology
1.2.4 Others
1.3 Market by Application
1.3.1 Global Ocular Gene Therapy Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospitals
1.3.3 Diagnostics Centers
1.3.4 Research Institutes
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Ocular Gene Therapy Market Perspective (2021–2032)
2.2 Global Ocular Gene Therapy Growth Trends by Region
2.2.1 Global Ocular Gene Therapy Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Ocular Gene Therapy Historic Market Size by Region (2021–2026)
2.2.3 Ocular Gene Therapy Forecasted Market Size by Region (2027–2032)
2.3 Ocular Gene Therapy Market Dynamics
2.3.1 Ocular Gene Therapy Industry Trends
2.3.2 Ocular Gene Therapy Market Drivers
2.3.3 Ocular Gene Therapy Market Challenges
2.3.4 Ocular Gene Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Ocular Gene Therapy Players by Revenue
3.1.1 Global Top Ocular Gene Therapy Players by Revenue (2021–2026)
3.1.2 Global Ocular Gene Therapy Revenue Market Share by Players (2021–2026)
3.2 Global Top Ocular Gene Therapy Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Ocular Gene Therapy Revenue
3.4 Global Ocular Gene Therapy Market Concentration Ratio
3.4.1 Global Ocular Gene Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ocular Gene Therapy Revenue in 2025
3.5 Global Key Players of Ocular Gene Therapy Head Offices and Areas Served
3.6 Global Key Players of Ocular Gene Therapy, Products and Applications
3.7 Global Key Players of Ocular Gene Therapy, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Ocular Gene Therapy Breakdown Data by Type
4.1 Global Ocular Gene Therapy Historic Market Size by Type (2021–2026)
4.2 Global Ocular Gene Therapy Forecasted Market Size by Type (2027–2032)
5 Ocular Gene Therapy Breakdown Data by Application
5.1 Global Ocular Gene Therapy Historic Market Size by Application (2021–2026)
5.2 Global Ocular Gene Therapy Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Ocular Gene Therapy Market Size (2021–2032)
6.2 North America Ocular Gene Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Ocular Gene Therapy Market Size by Country (2021–2026)
6.4 North America Ocular Gene Therapy Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Ocular Gene Therapy Market Size (2021–2032)
7.2 Europe Ocular Gene Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Ocular Gene Therapy Market Size by Country (2021–2026)
7.4 Europe Ocular Gene Therapy Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Ocular Gene Therapy Market Size (2021–2032)
8.2 Asia-Pacific Ocular Gene Therapy Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Ocular Gene Therapy Market Size by Region (2021–2026)
8.4 Asia-Pacific Ocular Gene Therapy Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Ocular Gene Therapy Market Size (2021–2032)
9.2 Latin America Ocular Gene Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Ocular Gene Therapy Market Size by Country (2021–2026)
9.4 Latin America Ocular Gene Therapy Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Ocular Gene Therapy Market Size (2021–2032)
10.2 Middle East & Africa Ocular Gene Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Ocular Gene Therapy Market Size by Country (2021–2026)
10.4 Middle East & Africa Ocular Gene Therapy Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Ocular Gene Therapy Introduction
11.1.4 AbbVie Revenue in Ocular Gene Therapy Business (2021–2026)
11.1.5 AbbVie Recent Development
11.2 MeriaGTx
11.2.1 MeriaGTx Company Details
11.2.2 MeriaGTx Business Overview
11.2.3 MeriaGTx Ocular Gene Therapy Introduction
11.2.4 MeriaGTx Revenue in Ocular Gene Therapy Business (2021–2026)
11.2.5 MeriaGTx Recent Development
11.3 Regenxbio
11.3.1 Regenxbio Company Details
11.3.2 Regenxbio Business Overview
11.3.3 Regenxbio Ocular Gene Therapy Introduction
11.3.4 Regenxbio Revenue in Ocular Gene Therapy Business (2021–2026)
11.3.5 Regenxbio Recent Development
11.4 GenSight Biologics
11.4.1 GenSight Biologics Company Details
11.4.2 GenSight Biologics Business Overview
11.4.3 GenSight Biologics Ocular Gene Therapy Introduction
11.4.4 GenSight Biologics Revenue in Ocular Gene Therapy Business (2021–2026)
11.4.5 GenSight Biologics Recent Development
11.5 Astellas
11.5.1 Astellas Company Details
11.5.2 Astellas Business Overview
11.5.3 Astellas Ocular Gene Therapy Introduction
11.5.4 Astellas Revenue in Ocular Gene Therapy Business (2021–2026)
11.5.5 Astellas Recent Development
11.6 Neurophth Therapeutics
11.6.1 Neurophth Therapeutics Company Details
11.6.2 Neurophth Therapeutics Business Overview
11.6.3 Neurophth Therapeutics Ocular Gene Therapy Introduction
11.6.4 Neurophth Therapeutics Revenue in Ocular Gene Therapy Business (2021–2026)
11.6.5 Neurophth Therapeutics Recent Development
11.7 Innostellar Biotherapeutics
11.7.1 Innostellar Biotherapeutics Company Details
11.7.2 Innostellar Biotherapeutics Business Overview
11.7.3 Innostellar Biotherapeutics Ocular Gene Therapy Introduction
11.7.4 Innostellar Biotherapeutics Revenue in Ocular Gene Therapy Business (2021–2026)
11.7.5 Innostellar Biotherapeutics Recent Development
11.8 Exegenesis Bio
11.8.1 Exegenesis Bio Company Details
11.8.2 Exegenesis Bio Business Overview
11.8.3 Exegenesis Bio Ocular Gene Therapy Introduction
11.8.4 Exegenesis Bio Revenue in Ocular Gene Therapy Business (2021–2026)
11.8.5 Exegenesis Bio Recent Development
11.9 Zhongyin Technology
11.9.1 Zhongyin Technology Company Details
11.9.2 Zhongyin Technology Business Overview
11.9.3 Zhongyin Technology Ocular Gene Therapy Introduction
11.9.4 Zhongyin Technology Revenue in Ocular Gene Therapy Business (2021–2026)
11.9.5 Zhongyin Technology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Ocular Gene Therapy Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Gene Replacement Technology
Table 3. Key Players of Gene Editing Technology
Table 4. Key Players of Others
Table 5. Global Ocular Gene Therapy Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Ocular Gene Therapy Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Ocular Gene Therapy Market Size by Region (US$ Million), 2021–2026
Table 8. Global Ocular Gene Therapy Market Share by Region (2021–2026)
Table 9. Global Ocular Gene Therapy Forecasted Market Size by Region (US$ Million), 2027–2032
Table 10. Global Ocular Gene Therapy Market Share by Region (2027–2032)
Table 11. Ocular Gene Therapy Market Trends
Table 12. Ocular Gene Therapy Market Drivers
Table 13. Ocular Gene Therapy Market Challenges
Table 14. Ocular Gene Therapy Market Restraints
Table 15. Global Ocular Gene Therapy Revenue by Players (US$ Million), 2021–2026
Table 16. Global Ocular Gene Therapy Market Share by Players (2021–2026)
Table 17. Global Top Ocular Gene Therapy Players by Tier (Tier 1, Tier 2, and Tier 3), based on Ocular Gene Therapy Revenue, 2025
Table 18. Ranking of Global Top Ocular Gene Therapy Companies by Revenue (US$ Million) in 2025
Table 19. Global 5 Largest Players Market Share by Ocular Gene Therapy Revenue (CR5 and HHI), 2021–2026
Table 20. Global Key Players of Ocular Gene Therapy, Headquarters and Area Served
Table 21. Global Key Players of Ocular Gene Therapy, Products and Applications
Table 22. Global Key Players of Ocular Gene Therapy, Date of General Availability (GA)
Table 23. Mergers and Acquisitions, Expansion Plans
Table 24. Global Ocular Gene Therapy Market Size by Type (US$ Million), 2021–2026
Table 25. Global Ocular Gene Therapy Revenue Market Share by Type (2021–2026)
Table 26. Global Ocular Gene Therapy Forecasted Market Size by Type (US$ Million), 2027–2032
Table 27. Global Ocular Gene Therapy Revenue Market Share by Type (2027–2032)
Table 28. Global Ocular Gene Therapy Market Size by Application (US$ Million), 2021–2026
Table 29. Global Ocular Gene Therapy Revenue Market Share by Application (2021–2026)
Table 30. Global Ocular Gene Therapy Forecasted Market Size by Application (US$ Million), 2027–2032
Table 31. Global Ocular Gene Therapy Revenue Market Share by Application (2027–2032)
Table 32. North America Ocular Gene Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 33. North America Ocular Gene Therapy Market Size by Country (US$ Million), 2021–2026
Table 34. North America Ocular Gene Therapy Market Size by Country (US$ Million), 2027–2032
Table 35. Europe Ocular Gene Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 36. Europe Ocular Gene Therapy Market Size by Country (US$ Million), 2021–2026
Table 37. Europe Ocular Gene Therapy Market Size by Country (US$ Million), 2027–2032
Table 38. Asia-Pacific Ocular Gene Therapy Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 39. Asia-Pacific Ocular Gene Therapy Market Size by Region (US$ Million), 2021–2026
Table 40. Asia-Pacific Ocular Gene Therapy Market Size by Region (US$ Million), 2027–2032
Table 41. Latin America Ocular Gene Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 42. Latin America Ocular Gene Therapy Market Size by Country (US$ Million), 2021–2026
Table 43. Latin America Ocular Gene Therapy Market Size by Country (US$ Million), 2027–2032
Table 44. Middle East & Africa Ocular Gene Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Middle East & Africa Ocular Gene Therapy Market Size by Country (US$ Million), 2021–2026
Table 46. Middle East & Africa Ocular Gene Therapy Market Size by Country (US$ Million), 2027–2032
Table 47. AbbVie Company Details
Table 48. AbbVie Business Overview
Table 49. AbbVie Ocular Gene Therapy Product
Table 50. AbbVie Revenue in Ocular Gene Therapy Business (US$ Million), 2021–2026
Table 51. AbbVie Recent Development
Table 52. MeriaGTx Company Details
Table 53. MeriaGTx Business Overview
Table 54. MeriaGTx Ocular Gene Therapy Product
Table 55. MeriaGTx Revenue in Ocular Gene Therapy Business (US$ Million), 2021–2026
Table 56. MeriaGTx Recent Development
Table 57. Regenxbio Company Details
Table 58. Regenxbio Business Overview
Table 59. Regenxbio Ocular Gene Therapy Product
Table 60. Regenxbio Revenue in Ocular Gene Therapy Business (US$ Million), 2021–2026
Table 61. Regenxbio Recent Development
Table 62. GenSight Biologics Company Details
Table 63. GenSight Biologics Business Overview
Table 64. GenSight Biologics Ocular Gene Therapy Product
Table 65. GenSight Biologics Revenue in Ocular Gene Therapy Business (US$ Million), 2021–2026
Table 66. GenSight Biologics Recent Development
Table 67. Astellas Company Details
Table 68. Astellas Business Overview
Table 69. Astellas Ocular Gene Therapy Product
Table 70. Astellas Revenue in Ocular Gene Therapy Business (US$ Million), 2021–2026
Table 71. Astellas Recent Development
Table 72. Neurophth Therapeutics Company Details
Table 73. Neurophth Therapeutics Business Overview
Table 74. Neurophth Therapeutics Ocular Gene Therapy Product
Table 75. Neurophth Therapeutics Revenue in Ocular Gene Therapy Business (US$ Million), 2021–2026
Table 76. Neurophth Therapeutics Recent Development
Table 77. Innostellar Biotherapeutics Company Details
Table 78. Innostellar Biotherapeutics Business Overview
Table 79. Innostellar Biotherapeutics Ocular Gene Therapy Product
Table 80. Innostellar Biotherapeutics Revenue in Ocular Gene Therapy Business (US$ Million), 2021–2026
Table 81. Innostellar Biotherapeutics Recent Development
Table 82. Exegenesis Bio Company Details
Table 83. Exegenesis Bio Business Overview
Table 84. Exegenesis Bio Ocular Gene Therapy Product
Table 85. Exegenesis Bio Revenue in Ocular Gene Therapy Business (US$ Million), 2021–2026
Table 86. Exegenesis Bio Recent Development
Table 87. Zhongyin Technology Company Details
Table 88. Zhongyin Technology Business Overview
Table 89. Zhongyin Technology Ocular Gene Therapy Product
Table 90. Zhongyin Technology Revenue in Ocular Gene Therapy Business (US$ Million), 2021–2026
Table 91. Zhongyin Technology Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
Table 95. Authors List of This Report


List of Figures
Figure 1. Ocular Gene Therapy Picture
Figure 2. Global Ocular Gene Therapy Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Ocular Gene Therapy Market Share by Type: 2025 vs 2032
Figure 4. Gene Replacement Technology Features
Figure 5. Gene Editing Technology Features
Figure 6. Others Features
Figure 7. Global Ocular Gene Therapy Market Size by Application (US$ Million), 2021–2032
Figure 8. Global Ocular Gene Therapy Market Share by Application: 2025 vs 2032
Figure 9. Hospitals Case Studies
Figure 10. Diagnostics Centers Case Studies
Figure 11. Research Institutes Case Studies
Figure 12. Ocular Gene Therapy Report Years Considered
Figure 13. Global Ocular Gene Therapy Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 14. Global Ocular Gene Therapy Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Ocular Gene Therapy Market Share by Region: 2025 vs 2032
Figure 16. Global Ocular Gene Therapy Market Share by Players in 2025
Figure 17. Global Ocular Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by Ocular Gene Therapy Revenue in 2025
Figure 19. North America Ocular Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 20. North America Ocular Gene Therapy Market Share by Country (2021–2032)
Figure 21. United States Ocular Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Canada Ocular Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe Ocular Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Ocular Gene Therapy Market Share by Country (2021–2032)
Figure 25. Germany Ocular Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. France Ocular Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. U.K. Ocular Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Italy Ocular Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Russia Ocular Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Ireland Ocular Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific Ocular Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Ocular Gene Therapy Market Share by Region (2021–2032)
Figure 33. China Ocular Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Japan Ocular Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. South Korea Ocular Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Southeast Asia Ocular Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. India Ocular Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Australia & New Zealand Ocular Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America Ocular Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Ocular Gene Therapy Market Share by Country (2021–2032)
Figure 41. Mexico Ocular Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Brazil Ocular Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa Ocular Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Ocular Gene Therapy Market Share by Country (2021–2032)
Figure 45. Israel Ocular Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Saudi Arabia Ocular Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. UAE Ocular Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. AbbVie Revenue Growth Rate in Ocular Gene Therapy Business (2021–2026)
Figure 49. MeriaGTx Revenue Growth Rate in Ocular Gene Therapy Business (2021–2026)
Figure 50. Regenxbio Revenue Growth Rate in Ocular Gene Therapy Business (2021–2026)
Figure 51. GenSight Biologics Revenue Growth Rate in Ocular Gene Therapy Business (2021–2026)
Figure 52. Astellas Revenue Growth Rate in Ocular Gene Therapy Business (2021–2026)
Figure 53. Neurophth Therapeutics Revenue Growth Rate in Ocular Gene Therapy Business (2021–2026)
Figure 54. Innostellar Biotherapeutics Revenue Growth Rate in Ocular Gene Therapy Business (2021–2026)
Figure 55. Exegenesis Bio Revenue Growth Rate in Ocular Gene Therapy Business (2021–2026)
Figure 56. Zhongyin Technology Revenue Growth Rate in Ocular Gene Therapy Business (2021–2026)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed

Your Name

Your E-mail

Your message

Submit